|
|
|
Insider
Information: |
Ho Carole |
Relationship: |
Chief Medical Officer |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
118,810 |
|
Indirect Shares
|
208,219 |
|
|
Direct
Value |
$3,592,814 |
|
|
Indirect Value
|
$6,296,543 |
|
|
Total
Shares |
327,029 |
|
|
Total
Value |
$9,889,357 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
7
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-7.0
|
Percentage
Gain/Loss : |
0.0%
|
-332.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-08-21 |
118,810 |
2024-08-21 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
111 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-02-05 |
4 |
OE |
$5.28 |
$41,480 |
D/D |
7,856 |
7,856 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-01 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
5,775 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-01 |
4 |
AS |
$22.17 |
$129,495 |
D/D |
(5,775) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-04 |
4 |
OE |
$5.28 |
$30,957 |
D/D |
5,863 |
5,863 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-04 |
4 |
AS |
$21.87 |
$129,776 |
D/D |
(5,863) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-05 |
4 |
AS |
$21.96 |
$128,730 |
D/D |
(5,862) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-05 |
4 |
OE |
$5.28 |
$30,951 |
D/D |
5,862 |
5,862 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-14 |
4 |
AS |
$25.01 |
$12,505 |
D/D |
(500) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-14 |
4 |
OE |
$5.28 |
$2,640 |
D/D |
500 |
500 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-03-14 |
4 |
AS |
$25.01 |
$12,505 |
I/I |
(500) |
142,115 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-01 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
5,775 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-01 |
4 |
AS |
$23.91 |
$138,080 |
D/D |
(5,775) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4/A |
OE |
$5.28 |
$32,958 |
D/D |
6,242 |
6,242 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4/A |
AS |
$24.51 |
$155,194 |
D/D |
(6,242) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
AS |
$25.29 |
$238,864 |
I/I |
(9,445) |
132,670 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
OE |
$5.28 |
$32,393 |
D/D |
6,135 |
6,135 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-02 |
4 |
AS |
$24.51 |
$152,503 |
D/D |
(6,135) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-03 |
4 |
AS |
$26.27 |
$154,319 |
D/D |
(5,862) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-03 |
4 |
OE |
$5.28 |
$30,951 |
D/D |
5,862 |
5,862 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-03 |
4 |
AS |
$26.29 |
$252,519 |
I/I |
(9,588) |
123,082 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-04-04 |
4 |
AS |
$26.24 |
$252,678 |
I/I |
(9,588) |
113,494 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-05-08 |
4 |
AS |
$23.51 |
$74,339 |
I/I |
(3,162) |
110,332 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-05-08 |
4 |
AS |
$23.50 |
$61,406 |
D/D |
(2,613) |
0 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-05-08 |
4 |
OE |
$5.28 |
$13,797 |
D/D |
2,613 |
2,613 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
|
2019-05-09 |
4 |
AS |
$22.83 |
$73,438 |
I/I |
(3,210) |
107,122 |
0 |
- |
|
111 Records found
|
|
Page 2 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|